近日,美国食品药品管理局(FDA)在抗感染药物顾问委员会精神病药物及儿科专业组的建议下发出一则公共卫生通告,提醒医生、抑郁症患者本人及其家属在患者服用某些新型抗抑郁药的初期,以及在改变给药剂量的时候,应密切观察患者的表现,以防患者出现症状加重或自杀行为。与此同时,FD Recently, the U.S. Food and Drug Administration (FDA) issued a public health circular under the recommendation of the Psychotropic Substances and Pediatric Unit of the Advisory Board on Anti-infectives to remind doctors that depression patients themselves and their families are taking some new antidepressants In the early stages of medicine, and in changing the dose, patients should be closely monitored for their performance in case of exacerbations or suicidal behavior. At the same time, FD